LINC00305 promotes an interaction between the membrane protein lipocalin-interacting membrane receptor (LIMR) and the inflammatory gene aryl hydrocarbon receptor repressor (AHRR) via activation of the NF-kappaB pathway in human monocytes, further contributing to the development of atherosclerosis [217]. Here, LINC00305 is linked to atherosclerosis.